A comprehensive view of Approval Recommendations. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Bristol Myers Squibb reports European Medicines Agency’s Committee for Medicinal Products for Human Use recommends approval of Reblozyl luspatercept to treat adult patients with anemia associated with non-transfusion-dependent beta thalassemia
Published: January 30, 2023 by ENP Newswire
Eli Lilly reports FDA has rejected accelerated approval for its donanemab Alzheimer’s drug due to insufficient data from patients who used the drug for a year; donanemab removes amyloid protein plaques from the brains of people with early Alzheimer's
Published: January 20, 2023 by International Business Times
Eli Lilly’s tirzepatide weight loss treatment could be best-selling drug of all time if it receives FDA approval, with estimated annual sales reaching US$48.0B; approval decision expected next year
Published: January 03, 2023 by NBC - 8 WFLA
Oregon approves Amazon’s proposed US$3.9B acquisition of primary care provider One Medical, which has five clinics in Oregon; deal still needs FTC approval
Published: December 29, 2022 by Seattle Times
European Medicines Agency recommends authorizing AstraZeneca’s Imfinzi and Imjudo combinations for adults with advanced liver and lung cancers
Published: December 19, 2022 by dpa-AFX International Compact

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count